A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
Clinical trial NCT02298387 · COMPLETED
Trial details
- NCT number
- NCT02298387
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-22
- Primary completion
- 2017-05-23
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.